A synthetic peptide that disrupts the AF4-AF9 interaction in vivo causes cell death in MLL-AF4 leukemia cells [217,218], providing strong evidence that fusion protein complexes make key contributions to MLL-FP leukemogenesis. The gene discussed is MLLT3; the disease is leukemia.